Zacks Research Daily has released its latest analyst reports, spotlighting 16 major stocks with particular focus on Berkshire Hathaway (BRK.B), Roche Holding AG (RHHBY), and RTX Corp. (RTX).
Shares of Berkshire Hathaway have gained 2.5% over the past year, trailing the Zacks Insurance – Property and Casualty industry’s gain of 4.4% during the same period.
The company benefits from diversified businesses, disciplined underwriting, and a large liquidity base that support durable earnings capacity and flexible capital allocation.
Insurance float remains a low-cost funding source, while manufacturing, services, BNSF, and Berkshire Hathaway Energy continue to broaden the earnings mix for BRK.B investors.
Greg Abel is now leading the company, leaving execution under the new leadership structure as an important watchpoint that analysts and investors are monitoring closely.
Roche’s shares have outperformed the Zacks Large Cap Pharmaceuticals industry over the past year, rising 45.2% compared to the industry’s 43.7% gain despite foreign-exchange headwinds.
Multiple sclerosis drug Ocrevus, ophthalmology drug Vabysmo, hemophilia treatment Hemlibra, and breast cancer drug Phesgo all contributed meaningfully to Roche’s top-line performance.
A tentative approval of breast cancer candidate giredestrant could serve as a meaningful catalyst for the RHHBY stock going forward.
RTX has outperformed the Zacks Aerospace – Defense industry over the past year, gaining 33% compared to the industry’s decline of 3.1%, supported by strong defense orders and a robust backlog.
The company ended the second quarter of 2026 with a backlog of $289 billion, with cash generation funding expansion, innovation, and debt reduction across its operations.
However, persistent supply-chain disruptions, aircraft engine availability issues, tariff-related uncertainty, and expanded Russia-linked sanctions pose meaningful risks to RTX’s business.
Among the microcap stocks featured, Eastern Company (EML) enters the second half of 2026 with a $126.2 million backlog, up 45% year over year, though first-half sales fell 11% to $121.5 million.
AmeriServ Financial (ASRV) has outperformed the Zacks Banks – Northeast industry over the past year by a wide margin, gaining 62.8% versus the industry’s 26.7% advance.
AmeriServ’s net income increased 179% to $4.5 million in the first half of 2026, while net interest margin expanded 24 basis points to 3.30%, aided by lower deposit costs and reduced borrowing reliance.
Other noteworthy reports featured by Zacks today include Lumentum Holdings Inc. (LITE), Public Storage (PSA), and Rocket Lab Corp. (RKLB), each carrying distinct risk-reward profiles heading into the second half of 2026.
